Bliss GVS Pharma Limited has informed the Exchange regarding Notice of Postal Ballot regrading appointment of Independent Directors of the Company.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma Limited is seeking shareholder approval via postal ballot for appointing two new Independent Directors - Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah. Both candidates are Chartered Accountants with extensive experience spanning 35+ years. Mr. Mahadevan has a background in global pharma and finance leadership at companies like Alcon, Novartis, and SHV Energy. Mr. Shah brings expertise in direct and indirect taxation, has served as President of Bombay Chartered Accountants Society, and currently serves on boards of Ruby Mills, Marathon Nextgen Realty, and Siyaram Silk Mills. Both appointments are for a term of five years commencing April 3, 2026. The e-voting period runs from April 10, 2026 to May 9, 2026, with results to be declared by May 12, 2026.
These appointments strengthen the board's independence and governance structure. The addition of two experienced independent directors is generally positive for corporate governance and may boost investor confidence.